You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

daratumumab

Showing 51 - 75 of 153
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Houston (biological,

Active, not recruiting
  • Prostate Adenocarcinoma
  • +5 more
  • Daratumumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

Recurrent Plasma Cell Myeloma Trial in United States (Daratumumab, Dexamethasone, Pomalidomide)

Withdrawn
  • Recurrent Plasma Cell Myeloma
  • Daratumumab
  • +2 more
  • Wichita, Kansas
  • +4 more
Jun 13, 2022

Multiple Myeloma Trial in Washington, Hackensack (Selinexor 60 MG, Selinexor 80 MG, Selinexor 100 MG)

Recruiting
  • Multiple Myeloma
  • Selinexor 60 MG
  • +6 more
  • Washington, District of Columbia
  • +1 more
Feb 3, 2022

Maintenance With Bortezomib Plus Daratumumab After Induction

Recruiting
  • Multiple Myeloma
  • Non-eligible for Autologous Stem Cell Transplantation (ASCT)
  • Arganda Del Rey, Spain
  • +31 more
Sep 15, 2022

Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (biological, drug, other)

Recruiting
  • Plasma Cell Myeloma
  • +2 more
  • Belantamab Mafodotin
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 10, 2022

Plasma Cell Leukemia Trial (Daratumumab)

Not yet recruiting
  • Plasma Cell Leukemia
  • Daratumumab
  • (no location specified)
Sep 22, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (drug, biological, other)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Des Moines, Iowa
  • +8 more
Jan 12, 2023

Multiple Myeloma in Relapse Trial in Canada (Daratumumab)

Completed
  • Multiple Myeloma in Relapse
  • Daratumumab
  • Kingston, Ontario, Canada
  • +5 more
Feb 14, 2022

MDS Trial in Worldwide (Talacotuzumab, Daratumumab)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
  • +20 more
Dec 28, 2022

Newly Diagnosed Multiple Myeloma Trial (Daratumumab)

Not yet recruiting
  • Newly Diagnosed Multiple Myeloma
  • Daratumumab
  • (no location specified)
Oct 10, 2021

Multiple Myeloma, Refractory Multiple Myeloma, Multiple Myeloma in Relapse Trial in Boston (Daratumumab, Carfilzomib,

Recruiting
  • Multiple Myeloma
  • +3 more
  • Daratumumab
  • +3 more
  • Boston, Massachusetts
  • +2 more
Oct 28, 2021

Plasma Cell Myeloma, Secondary Amyloidosis Trial in Duarte, Nashville (procedure, biological, other, drug)

Recruiting
  • Plasma Cell Myeloma
  • Secondary Amyloidosis
  • Autologous Hematopoietic Stem Cell Transplantation
  • +3 more
  • Duarte, California
  • +1 more
Dec 27, 2021

Multiple Myeloma Trial in Worldwide (Melphalan flufenamide (Melflufen), Dexamethasone, Bortezomib)

Terminated
  • Multiple Myeloma
  • Melphalan flufenamide (Melflufen)
  • +3 more
  • Boston, Massachusetts
  • +15 more
Mar 4, 2022

Pancreatic Ductal Adenocarcinoma, Refractory NSCLC Trial in Washington (Daratumumab, KRAS vaccine, Nivolumab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Refractory Non-Small Cell Lung Cancer
  • Daratumumab
  • +2 more
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Sep 1, 2023

Multiple Myeloma Trial in United States (Carfilzomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +11 more
Aug 11, 2022

Plasma Cell Myeloma, Renal Failure Trial in Atlanta (Bortezomib, Daratumumab, Dexamethasone)

Recruiting
  • Plasma Cell Myeloma
  • Renal Failure
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jun 13, 2022

Myeloma, Multiple Myeloma Trial in Chicago (Daratumumab, Carfilzomib, Lenalidomide)

Recruiting
  • Myeloma
  • Multiple Myeloma
  • Daratumumab
  • +3 more
  • Chicago, Illinois
    The University of Chicago
Sep 15, 2021

Myeloma Multiple, Myeloma, Plasma-Cell, Myeloma-Multiple Trial in Israel (Carfilzomib, Daratumumab, Lenalidomide)

Completed
  • Myeloma Multiple
  • +3 more
  • Afula, Israel
  • +13 more
Jan 26, 2022

NHL, Multiple Myeloma, Blood Cancer Trial in Minneapolis, Houston, Fairfax (IDP-023, Rituximab, Daratumumab)

Recruiting
  • NHL
  • +6 more
  • Minneapolis, Minnesota
  • +2 more
Nov 7, 2023

Membranoproliferative Glomerulonephritis Trial in Rochester (Daratumumab)

Completed
Has Results
  • Membranoproliferative Glomerulonephritis
  • Daratumumab
  • Rochester, Minnesota
    Mayo Clinic
Jun 28, 2021

Multiple Myeloma Trial (Daratumumab, Cyclophosphamide, Pomalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Daratumumab
  • +3 more
  • (no location specified)
Oct 8, 2021

Light Chain (AL) Amyloidosis, Stage 3B Trial in Worldwide (Daratumumab, Bortezomib Injection, Dexamethasone oral tablet)

Recruiting
  • Light Chain (AL) Amyloidosis, Stage 3B
  • Daratumumab
  • +2 more
  • Créteil, France
  • +4 more
Sep 29, 2021

Monoclonal Gammopathy, Smoldering Multiple Myeloma Trial in United States (Daratumumab)

Active, not recruiting
  • Monoclonal Gammopathy
  • Smoldering Multiple Myeloma
  • Daratumumab
  • Monterey, California
  • +5 more
Nov 1, 2021

High-risk Smoldering Multiple Myeloma, Multiple Myeloma Trial in Boston (Daratumumab, Bortezomib, Lenalidomide)

Recruiting
  • High-risk Smoldering Multiple Myeloma
  • Multiple Myeloma
  • Daratumumab
  • +3 more
  • Boston, Massachusetts
  • +1 more
Oct 18, 2021

AL Amyloidosis Trial in Palo Alto, Detroit, Cleveland (CAEL-101, SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD),

Active, not recruiting
  • AL Amyloidosis
  • Palo Alto, California
  • +2 more
Dec 6, 2022